09 July 2019
: Case report
Simultaneous Liver-Kidney Transplantation in Patient with a History of Heparin-Induced Thrombocytopenia: A Case Report and Literature Review
Unknown etiology, Unusual setting of medical care
Kazuhiro Taguchi12ABCDEFG*, Kohei Ishiyama13ABCDEFG, Kentaro Ide1BCD, Masahiro Ohira1ABCD, Hiroyuki Tahara1BCD, Hideki Ohdan1ADGDOI: 10.12659/AJCR.916717
Am J Case Rep 2019; 20:980-987
Abstract
BACKGROUND: Heparin-induced thrombocytopenia (HIT) is the development of thrombocytopenia caused by exposure to heparin. Here, we report the case of a 58-year-old male with HIT who then underwent a successful simultaneous liver-kidney transplantation (SLKT).
CASE REPORT: The patient had end-stage hepatitis due to a hepatitis C virus (HCV) infection and was on hemodialysis due to nephropathy related to HCV. Furthermore, he was diagnosed with HIT caused by the administration of heparin for hemodialysis during these treatments. Fortunately, there was no evidence of thromboses and HIT antibody converted negative immediately. Four years after the occurrence of HIT, SLKT was performed for liver and kidney failure. Although the donor was heparinized, the donor grafts were flushed on a backtable by an organ preservation solution without heparin to reduce residual heparin. The subsequent transplantation was uneventful. After the operation, anticoagulation with argatroban, a direct thrombin inhibitor, was started instead of heparin. In the postoperative course, neither thrombosis nor graft dysfunction occurred.
CONCLUSIONS: SLKT in a patient who had a history of HIT could be performed safely.
Keywords: Heparin, Iatrogenic Disease, Kidney Transplantation, Liver Transplantation, Thrombocytopenia, Anticoagulants, Hepatitis C
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948238
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947782
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947794
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947096
Most Viewed Current Articles
21 Jun 2024 : Case report
100,489
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
53,790
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
36,376
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
25,034
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200